Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Crystal Oechsle
Addition of Anti-Estrogen Therapy to Anti-Her2 Dendritic Cell Vaccination Improves Regional Nodal Immune Response and Pathologic Complete Response Rate in Patients With ERpos/HER2pos Early Breast Cancer
OncoImmunology
Oncology
Allergy
Immunology
Related publications
Anti-Her2 CD4+ T-Helper Type 1 Response Is a Novel Immune Correlate to Pathologic Response Following Neoadjuvant Therapy in HER2-positive Breast Cancer
Breast Cancer Research
Cancer Research
Oncology
Dynamic Changes in CD44v-positive Cells After Preoperative Anti-Her2 Therapy and Its Correlation With Pathologic Complete Response in HER2-positive Breast Cancer
Oncotarget
Oncology
Selective Recruitment of Breast Cancer Anti-Estrogen Resistance Genes and Relevance for Breast Cancer Progression and Tamoxifen Therapy Response
Endocrine-Related Cancer
Cancer Research
Endocrinology
Oncology
Metabolism
Diabetes
Sequential Anti-Pd1 Therapy Following Dendritic Cell Vaccination Improves Survival in a HER2 Mammary Carcinoma Model and Identifies a Critical Role for CD4 T Cells in Mediating the Response
Frontiers in Immunology
Allergy
Immunology
Predictors of Recurrence in Breast Cancer Patients With a Pathologic Complete Response After Neoadjuvant Chemotherapy
British Journal of Cancer
Cancer Research
Oncology
Complete Response in HER2+ Leptomeningeal Carcinomatosis From Breast Cancer With Intrathecal Trastuzumab
Breast Cancer Research and Treatment
Cancer Research
Oncology
BioPATH: A Biomarker Study in Asian Patients With HER2+ Advanced Breast Cancer Treated With Lapatinib and Other Anti-Her2 Therapy
Cancer Research and Treatment
Cancer Research
Oncology
In Vitro Enhancement of Dendritic Cell-Mediated Anti-Glioma Immune Response by Graphene Oxide
Nanoscale Research Letters
Materials Science
Nanotechnology
Condensed Matter Physics
Nanoscience
Hormone Receptor-Negative as a Predictive Factor for Pathologic Complete Response to Neoadjuvant Therapy in Breast Cancer
Einstein (São Paulo, Brazil)
Medicine
